This inventor holds 1 USPTO granted patent. Top assignee: Lead Biologics International Ab. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Niklas Landberg: Inventor in Hematologic Disease Research
Introduction
Niklas Landberg is an inventor based in Malmö, Sweden. His patent work concerns agents that target SLAMF6, a protein relevant to pathological cells and immune-cell interactions in neoplastic hematologic disorders. Landberg is associated with Lead Biologics International AB.
Latest Patents
Landberg is named on one patent, 1 patent, titled “Agents and Uses Thereof.” The invention describes agents with binding specificity for Signaling Lymphocytic Activating Molecule Family Member 6 (SLAMF6). These agents are intended to induce cell death or inhibit the growth and proliferation of pathological stem cells and progenitor cells associated with neoplastic hematologic disorders when those cells express SLAMF6. The patent also describes using the agents to modulate interactions between such cells and immune cells, and to detect SLAMF6-expressing pathological stem cells, progenitor cells, or immune cells. It further covers related pharmacological compositions and methods of use.
Career Highlights
The available information identifies Landberg’s patent activity in the field of targeted agents for hematologic disorders. His work focuses on SLAMF6 as a potential target for detecting and affecting disease-associated cells.
Collaborations
Landberg’s listed coworkers include Thoas Fioretos and Carl Sandén. The patent information connects his work with Lead Biologics International AB.
Conclusion
Niklas Landberg’s documented invention explores SLAMF6-targeting agents for detecting and addressing pathological cells associated with neoplastic hematologic disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile